"NF-kappa B" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Ubiquitous, inducible, nuclear transcriptional activator that binds to enhancer elements in many different cell types and is activated by pathogenic stimuli. The NF-kappa B complex is a heterodimer composed of two DNA-binding subunits: NF-kappa B1 and relA.
| Descriptor ID |
D016328
|
| MeSH Number(s) |
D12.776.260.600 D12.776.660.600 D12.776.930.600
|
| Concept/Terms |
NF-kappa B- NF-kappa B
- kappa B Enhancer Binding Protein
- NF-kappaB
- NF kappaB
- Transcription Factor NF-kB
- Factor NF-kB, Transcription
- NF-kB, Transcription Factor
- Transcription Factor NF kB
- NF-kB
- NF kB
- Immunoglobulin Enhancer-Binding Protein
- Enhancer-Binding Protein, Immunoglobulin
- Immunoglobulin Enhancer Binding Protein
- Nuclear Factor kappa B
|
Below are MeSH descriptors whose meaning is more general than "NF-kappa B".
Below are MeSH descriptors whose meaning is more specific than "NF-kappa B".
This graph shows the total number of publications written about "NF-kappa B" by people in this website by year, and whether "NF-kappa B" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 5 | 1 | 6 |
| 1996 | 7 | 6 | 13 |
| 1997 | 9 | 3 | 12 |
| 1998 | 8 | 7 | 15 |
| 1999 | 18 | 5 | 23 |
| 2000 | 20 | 12 | 32 |
| 2001 | 24 | 11 | 35 |
| 2002 | 29 | 16 | 45 |
| 2003 | 30 | 23 | 53 |
| 2004 | 28 | 22 | 50 |
| 2005 | 32 | 18 | 50 |
| 2006 | 27 | 23 | 50 |
| 2007 | 30 | 25 | 55 |
| 2008 | 27 | 20 | 47 |
| 2009 | 26 | 31 | 57 |
| 2010 | 29 | 23 | 52 |
| 2011 | 20 | 32 | 52 |
| 2012 | 26 | 30 | 56 |
| 2013 | 14 | 16 | 30 |
| 2014 | 11 | 25 | 36 |
| 2015 | 11 | 26 | 37 |
| 2016 | 9 | 19 | 28 |
| 2017 | 13 | 24 | 37 |
| 2018 | 7 | 13 | 20 |
| 2019 | 5 | 11 | 16 |
| 2020 | 6 | 8 | 14 |
| 2021 | 8 | 8 | 16 |
| 2022 | 2 | 15 | 17 |
| 2023 | 4 | 8 | 12 |
| 2024 | 4 | 9 | 13 |
To return to the timeline,
click here.
Below are the most recent publications written about "NF-kappa B" by people in Profiles.
-
Clonal hematopoiesis-related mutant ASXL1 promotes atherosclerosis in mice via dysregulated innate immunity. Nat Cardiovasc Res. 2024 Dec; 3(12):1568-1583.
-
Administration of anti-HIV-1 broadly neutralizing monoclonal antibodies with increased affinity to Fc? receptors during acute SHIVAD8-EO infection. Nat Commun. 2024 Aug 29; 15(1):7461.
-
T-bet suppresses proliferation of malignant B cells in chronic lymphocytic leukemia. Blood. 2024 08 01; 144(5):510-524.
-
Presence of Fusobacterium nucleatum in relation to patient survival and an acidic environment in oesophagogastric junction and gastric cancers. Br J Cancer. 2024 Sep; 131(5):797-807.
-
Targeting MCL1-driven anti-apoptotic pathways overcomes blast progression after hypomethylating agent failure in chronic myelomonocytic leukemia. Cell Rep Med. 2024 Jun 18; 5(6):101585.
-
NF-?B Inducing Kinase Attenuates Colorectal Cancer by Regulating Noncanonical NF-?B Mediated Colonic Epithelial Cell Regeneration. Cell Mol Gastroenterol Hepatol. 2024; 18(3):101356.
-
ANKRD1 expression is aberrantly upregulated in the mdm mouse model of muscular dystrophy and induced by stretch through NF?B. J Muscle Res Cell Motil. 2024 Dec; 45(4):191-200.
-
CD24 negativity reprograms mitochondrial metabolism to PPARa and NF-?B-driven fatty acid ?-oxidation in triple-negative breast cancer. Cancer Lett. 2024 Apr 10; 587:216724.
-
Genome-wide CRISPR screen reveals the synthetic lethality between BCL2L1 inhibition and radiotherapy. Life Sci Alliance. 2024 04; 7(4).
-
PD-1 Blockade Induces Reactivation of Nonproductive T-Cell Responses Characterized by NF-?B Signaling in Patients with Pancreatic Cancer. Clin Cancer Res. 2024 02 01; 30(3):542-553.